Citation 101128

CIMANGA,K: DE BRUYNE,T: LASURE,A: VAN POEL,B: PIETERS,L: CLAEYS,M: VANDEN BERGHE,D: KAMBU,K: TONA,L: VLIETINCK,AJ:. (1996). IN VITRO BIOLOGICAL ACTIVITIES OF ALKALOIDS FROM CRYPTOLEPIS SANGUINOLENTA.. 62(1)

Citation Details

Title	IN VITRO BIOLOGICAL ACTIVITIES OF ALKALOIDS FROM CRYPTOLEPIS SANGUINOLENTA.
Authors	CIMANGA,K: DE BRUYNE,T: LASURE,A: VAN POEL,B: PIETERS,L: CLAEYS,M: VANDEN BERGHE,D: KAMBU,K: TONA,L: VLIETINCK,AJ:
Year	1996
Volume	62
Issue	1

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Cryptolepis sanguinolenta (ASCLEPIADACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
3	ANTIYEAST ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
7	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	INACTIVE
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
13	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	QUINDOLINE	None
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	ACTIVE
15	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	INACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	EQUIVOCAL
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	INACTIVE
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	INACTIVE
19	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	ACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	ACTIVE
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	ACTIVE
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	INACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	INACTIVE
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUINDOLINE	ACTIVE
25	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINDOLINE	WEAK ACTIVITY
26	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CRYPTOLEPINE,HYDROXY:	None
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	EQUIVOCAL
28	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	EQUIVOCAL
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	EQUIVOCAL
30	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	ACTIVE
31	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	INACTIVE
32	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	EQUIVOCAL
33	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	ACTIVE
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	EQUIVOCAL
35	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	INACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	ACTIVE
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE,HYDROXY:	ACTIVE
38	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOLEPINE,HYDROXY:	WEAK ACTIVITY
39	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CRYPTOLEPINE HCL	None
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	EQUIVOCAL
41	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	INACTIVE
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	EQUIVOCAL
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	INACTIVE
44	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	INACTIVE
45	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	ACTIVE
46	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	ACTIVE
47	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	EQUIVOCAL
48	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	INACTIVE
49	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	EQUIVOCAL
50	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE HCL	ACTIVE
51	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOLEPINE HCL	WEAK ACTIVITY
52	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CRYPTOLEPINE	None
53	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	ACTIVE
54	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	ACTIVE
55	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	ACTIVE
56	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	EQUIVOCAL
57	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	INACTIVE
58	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	ACTIVE
59	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	ACTIVE
60	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	INACTIVE
61	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	INACTIVE
62	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	ACTIVE
63	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CRYPTOLEPINE	ACTIVE
64	ANTICOMPLEMENT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOLEPINE	WEAK ACTIVITY

Citation 101128

Citation Details

Summary

Organisms and Their Experiments (1)

Cryptolepis sanguinolenta (ASCLEPIADACEAE)

Show SPARQL Queries (1)

Query 1